New Partnership to Define Neuroinflammatory Progression in Neurodegenerative Diseases

Tuesday, August 13, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CereHealth Corporation Will Provide Quantitative Brain Imaging Analytics and Clinical Research Support to Bioscience Pharma Partners, LLC

CereHealth Corporation

Bioscience Pharma Partners, LLC

John Kelley

Jason Kralic

CEO

Director of Business Development

+1-720-259-1875

+1-919-491-4995

jkelley@cerescan.com

jason@biosciencepharma.com  

www.cerescan.com

www.biosciencepharma.com  

https://ceremetrix.io/



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store